| Mesoporous silica formulation strategies for drug dissolution enhancement: a review CA McCarthy, RJ Ahern, R Dontireddy, KB Ryan, AM Crean Expert opinion on drug delivery 13 (1), 93-108, 2016 | 189 | 2016 |
| In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation CA McCarthy, W Faisal, JP O'Shea, C Murphy, RJ Ahern, KB Ryan, ... Journal of Controlled Release 250, 86-95, 2017 | 42 | 2017 |
| Role of drug adsorption onto the silica surface in drug release from mesoporous silica systems CA McCarthy, RJ Ahern, KJ Devine, AM Crean Molecular Pharmaceutics 15 (1), 141-149, 2018 | 41 | 2018 |
| Comparison of drug release and adsorption under supersaturating conditions for ordered mesoporous silica with indomethacin or indomethacin methyl ester CA McCarthy, DY Zemlyanov, AM Crean, LS Taylor Molecular Pharmaceutics 17 (8), 3062-3074, 2020 | 12 | 2020 |
| Multiple layers of intelligence for complete distribution grid response and control CA McCarthy PES T&D 2012, 1-4, 2012 | 3 | 2012 |
| Drug dissolution from mesoporous silica systems CA McCarthy University College Cork, 2018 | | 2018 |
| Influence of adsorption/desorption behaviour of drug molecules on dissolution from silica carriers; can the presence of surfactants influence this process? CA McCarthy, AM Crean 2017 Controlled Release Society Annual Meeting, 2017 | | 2017 |
| Downloaded on 2018-12-14T20: 11: 54Z CA McCarthy, W Faisal, JP O'Shea, C Murphy, RJ Ahern, KB Ryan, ... | | |
| Downloaded on 2018-08-23T18: 16: 00Z CA McCarthy, W Faisal, JP O'Shea, C Murphy, RJ Ahern, KB Ryan, ... | | |
